22 results on '"Marcq, Gautier"'
Search Results
2. MP35-11 LONG-TERM ONCOLOGICAL OUTCOMES OF DE NOVO BLADDER CANCER IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS FROM A LARGE MULTICENTER INTERNATIONAL COHORT
3. PD34-12 THE OPTIMAL NUMBER OF INDUCTION CHEMOTHERAPY CYCLES IN CLINICALLY LYMPH NODE-POSITIVE BLADDER CANCER
4. MP32-11 FACTORS THAT PREDICT EARLY SALVAGE CYSTECTOMY POST-TRIMODAL THERAPY: RESULTS OF A MULTI-INSTITUTIONAL CANADIAN COHORT
5. PD09-02 THE IMPACT OF VARIANT HISTOLOGY ON CLINICAL OUTCOMES AFTER RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
6. MP63-17 PHOTODYNAMIC DIAGNOSIS (PDD) DIRECTED BIOPSIES VS WHITE LIGHT BLADDER MAPPING IN PATIENTS WITH POSITIVE CYTOLOGY AND NEGATIVE PREOPERATIVE WORKUP: AN INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY
7. PD44-08 BENEFIT OF WHOLE-PELVIS RADIATION FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: AN INVERSE PROBABILITY TREATMENT WEIGHTED ANALYSIS
8. PD44-02 EFFECT OF GENDER ON SURVIVAL OUTCOMES AFTER TRIMODAL THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
9. MP56-01 THE EFFECT OF DIFFERENT CONCURRENT CHEMOTHERAPY REGIMENS ON OUTCOMES IN PATIENTS TREATED WITH RADIATION FOR MUSCLE INVASIVE BLADDER CANCER
10. MP23-04 BENEFIT OF NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER CANCER PATIENTS TREATED WITH RADIATION-BASED THERAPY: AN INVERSE PROBABILITY TREATMENT WEIGHTED ANALYSIS
11. Reply by Authors
12. Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer
13. PD42-06 BOOSTING THE COMBINATION OF RADIATION AND ANTI-PD-L1 WITH STING AGONIST IN A PRECLINICAL MUSCLE INVASIVE BLADDER CANCER MURINE MODEL
14. MP41-14 IMPACT OF PD-L1 EXPRESSION IN THE TUMOR MICROENVIRONMENT ON ONCOLOGICAL OUTCOMES FOR PATIENTS TREATED WITH TRIMODALITY THERAPY FOR MUSCLE INVASIVE BLADDER CANCER: A POTENTIAL BIOMARKER FOR PATIENT SELECTION?
15. PD51-12 WHOLE-PELVIS COMPARED TO BLADDER-ONLY RADIATION THERAPY PROLONGS OVERALL SURVIVAL IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS: RESULTS FROM A CANADIAN MULTI-CENTER COLLABORATIVE STUDY
16. MP82-06 NEW CLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMA TO ENHANCE RISK STRATIFICATION OF PATIENTS ELIGIBLE TO ENDOSCOPIC MANAGEMENT: AN INTERNATIONAL COLLABORATIVE STUDY
17. PD17-12 ONCOLOGICAL OUTCOMES OF FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR INTERMEDIATE RISK PROSTATE CANCER TREATMENT: A FIRST NORTH AMERICAN EXPERIENCE WITH FOCAL ONE ®
18. PD42-02 OPTIMIZING SEQUENCE OF THERAPY AND RADIATION DELIVERY WHEN COMBINED WITH PD-L1 IMMUNE-CHECKPOINT INHIBITION IN BLADDER CANCER
19. PD60-01 DEFINITIVE RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: THE CANADIAN MULTICENTER EXPERIENCE
20. PD20-02 EFFICACY AND SAFETY OF PADELIPORFIN VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR TREATMENT OF LOW-GRADE UPPER TRACT UROTHELIAL CANCER (LG UTUC): PHASE 3 PRELIMINARY RESULTS.
21. MP53-06 PREVALENCE AND PATHOLOGICAL CHARACTERISTICS OF ANTERIOR PROSTATE CANCER IN A COHORT OF RADICAL PROSTATECTOMY PATIENTS DIAGNOSED BY BIOPSIES AND MRI.
22. The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.